Back to search

Peptide record

TPDB65945

Tumor-homing Peptides standard
25 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB65945
Tumor-homing Peptides
Cancer-related peptides
TumorHoPe2.0
standard
No
A 25-aa standard natural tumor-homing peptides peptide sequence curated from TumorHoPe2.0, with an available 3D structural model.
Sequence
RCSHYTGIRCSHGIYTGIRCQHVVL
Physicochemical Analysis
C122H195N41O33S3
ANDEKMFPW
RCGHI
2860.33
9.12
6
0
8
+3
2.51
-0.008
85.60
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
3105
108.55
10
Residue Composition
number
0
A
3
R
0
N
0
D
3
C
0
E
1
Q
3
G
3
H
3
I
1
L
0
K
0
M
0
F
0
P
2
S
2
T
0
W
2
Y
2
V
Amino Acid Distribution
A: 0 R: 3 N: 0 D: 0 C: 3 E: 0 Q: 1 G: 3 H: 3 I: 3 L: 1 K: 0 M: 0 F: 0 P: 0 S: 2 T: 2 W: 0 Y: 2 V: 2
Chemical Descriptors
25
C122H195N41O33S3
2860.33
9.12
+3
2.51
-0.008
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Tumor cell
Targeting
EGFR

Source & Reference

TumorHoPe2.0
TumorHoPe2
Tumor targeting polypeptide and method of use thereof
2023
US 11566045 B2
US 11566045 B2

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
Synthetic
Linker peptide (HMAATT), chemotherapeutic agent (capecitabine, cisplatin, trastuzumab, fulvestrant, tamoxifen, letrozole, exemestane, anastrozole, aminoglutethimide, testolactone, vorozole, formestane, Fadrozole, letrozole, erlotinib, lafatinib, dasatinib, gefitinib, imatin, Imatinib, pazopinib, lapatinib, sunitinib, nilotinib, sorafenib, nab-palitaxel), radiotherapeutic agent (iodine-131, lutetium-177, yttrium-90, samarium-153, phospho-32, cesium-131, palladium-223, iodine-125, boron-10, actinium-225, bismuth-213, radium-225, lead-212, thorium-232)
Additional Detail Fields 1 fields
Linker peptide (HMAATT), chemotherapeutic agent (capecitabine, cisplatin, trastuzumab, fulvestrant, tamoxifen, letrozole, exemestane, anastrozole, aminoglutethimide, testolactone, vorozole, formestane, Fadrozole, letrozole, erlotinib, lafatinib, dasatinib, gefitinib, imatin, Imatinib, pazopinib, lapatinib, sunitinib, nilotinib, sorafenib, nab-palitaxel), radiotherapeutic agent (iodine-131, lutetium-177, yttrium-90, samarium-153, phospho-32, cesium-131, palladium-223, iodine-125, boron-10, actinium-225, bismuth-213, radium-225, lead-212, thorium-232)